Table 1 Clinical characteristics of the training set, validation set and entire set.
From: A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
Training set (N = 250) | Validation set (N = 250) | Entire set (N = 500) | |
|---|---|---|---|
Age (mean ± SD) | 60.99 ± 12.22 | 61.16 ± 11.62 | 61.08 ± 11.92 |
Sex (male/female) | 189/61 | 178/72 | 367/133 |
Clinical M (M0/M1) | 239/2 | 231/3 | 470/5 |
Clinical N (N0/N1/N2 + 3) | 127/36/78 | 112/44/81 | 239/81/159 |
Clinical T (T1/T2/T3/T4) | 20/74/59/90 | 13/69/71/89 | 33/143/130/179 |
Clinical stage (I/II/III/IV) | 12/49/48/135 | 7/46/54/135 | 19/95/102/270 |
Overall survival time (days) | 673 ± 862 | 662 ± 831 | 668 ± 846 |
Status (dead/alive) | 76/174 | 90/160 | 166/334 |
